Taro Pharmaceutical Industries Valuation

Taro Pharmaceutical Investor Information

About 78.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.89. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Taro Pharmaceutical last dividend was issued on the 10th of December 2018. The entity had 2:1 split on the 27th of July 2001. Taro Pharmaceutical Industries is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Taro Pharmaceutical Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Taro suggests not a very effective usage of assets in March.

Taro Pharmaceutical Ownership Allocation

Taro Pharmaceutical shows a total of 37.58 Million outstanding shares. Taro Pharmaceutical has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.48 % of Taro Pharmaceutical outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Taro Pharmaceutical Profitability Analysis

The company reported the previous year's revenue of 629.18 M. Net Income was 53.87 M with profit before overhead, payroll, taxes, and interest of 293.13 M.

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

If you are still planning to invest in Taro Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taro Pharmaceutical's history and understand the potential risks before investing.